アジェンダ
8:15 AM — 8:30 AM
8:30 AM — 8:45 AM
Welcome and Introduction8:45 AM — 9:15 AM
Session 1: Course Overview9:15 AM — 10:15 AM
Session 2: Defining “Risk” in the Context of Medicinal Drug Products10:15 AM — 10:30 AM
10:30 AM — 11:15 AM
Session 3: What are the Goals of Risk Communication?11:15 AM — 12:15 PM
Session 4: Exercise #1: Framing a Risk Communication Message12:15 PM — 1:15 PM
1:15 PM — 2:00 PM
Session 5: Basic Concepts for Designing Effective Risk Communication2:45 PM — 3:00 PM
4:30 PM — 4:45 PM
Questions and Answers and Daily Wrap-Up8:15 AM — 8:30 AM
8:30 AM — 9:15 AM
Session 9: Who’s Responsible for Communicating Drug Safety Information?9:15 AM — 10:15 AM
Session 10: Risk Communication and Risk Management in the US and EU10:15 AM — 10:30 AM
10:30 AM — 11:15 AM
Session 11: Risk Communication: Evaluating Effectiveness11:15 AM — 12:15 PM
Session 12: Exercise #3: Evaluating the Effectiveness of a Patient Alert Card12:15 PM — 1:15 PM
1:15 PM — 2:00 PM
Session 13: Effective Presentation of Statistical Risk Information2:00 PM — 2:15 PM
3:30 PM — 4:30 PM
Session 15: What Does the Future Hold?4:30 PM — 4:45 PM
Questions and Answers and Wrap-Up